Content related to Children’s Oncology Group Collaborators Publish Latest Findings on Post-Relapse Survival for Acute Lymphoblastic Leukemia

Four investigators share their research—and how the USC/CHLA facility will help bring novel cell therapies to clinical trials faster.

Every cancer treatment that now exists for children was tested in a clinical trial. Clinical research and clinical trials are the only way to develop new and better therapies for children who have

A CHLA study finds that preterm birth accounts for nearly a quarter of mortality in babies with congenital diaphragmatic hernia.

Hunter never let his acute lymphoblastic leukemia diagnosis define him—but today, he proudly wears the title “survivor” in support of cancer research.

A new study finds that blocking Artemis significantly reduces the proliferation of leukemia cells, without affecting normal cells.

Study shows that combining MIBG therapy with immunotherapy and vorinostat may boost response rates in patients with relapsed neuroblastoma.

A CHLA neuro-oncologist shares how using real-world data could make clinical trials more feasible for rare childhood brain tumors.

A CHLA oncologist is leading new research to improve outcomes for children, adolescents and young adults with relapsed or treatment-resistant germ cell tumors.

Poster session finalists were voted on by a scientific committee and presented key takeaways from their research during Science Day 2024.